NVO

Novo Nordisk A/s Earnings

$37.74

Earnings Summary

Revenue	$78434.81Mn
Net Profits	$26650.04Mn
Net Profit Margins	33.98%

Highlights

Revenue:

Novo Nordisk A/s’s revenue fell -8.46% since last year same period to $78434.81Mn in the Q4 2025. On a quarterly growth basis, Novo Nordisk A/s has generated 4.61% jump in its revenue since last 3-months.

Net Profits:

Novo Nordisk A/s’s net profit fell -5.6% since last year same period to $26650.04Mn in the Q4 2025. On a quarterly growth basis, Novo Nordisk A/s has generated 33.21% jump in its net profits since last 3-months.

Net Profit Margins:

Novo Nordisk A/s’s net profit margin jumped 3.13% since last year same period to 33.98% in the Q4 2025. On a quarterly growth basis, Novo Nordisk A/s has generated 27.34% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Novo Nordisk A/s post its latest quarter earnings

EPS Estimate Current Quarter	4.94
EPS Estimate Current Year	4.94

Highlights

EPS Estimate Current Quarter:

Novo Nordisk A/s’s earning per share (EPS) estimates for the current quarter stand at 4.94 - a -16.27% fall from last quarter’s estimates.

EPS Estimate Current Year:

Novo Nordisk A/s’s earning per share (EPS) estimates for the current year stand at 4.94.

Key Ratios

Key ratios of the Novo Nordisk A/s post its Q1 2026 earnings

Earning Per Share (EPS)	0
Dividend Per Share (DPS)	1.28

Highlights

Earning Per Share (EPS):

Novo Nordisk A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Novo Nordisk A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Dividend Per Share (DPS):

Novo Nordisk A/s declared 1.28 dividend per share during the earnings announcement for Q1 2026.